Therapeutic implications of the endocannabinoid system in neurodegenerative diseases

@inproceedings{Zogopoulos2015TherapeuticIO,
  title={Therapeutic implications of the endocannabinoid system in neurodegenerative diseases},
  author={Panagiotis Zogopoulos and Georgios Vretakos and Dimitrios Rologis},
  year={2015}
}
Over the last years, considerable progress has been made in understanding the role of the endocannabinoid system in the modulation of several progressive neurodegenerative diseases. The endocannabinoid system, comprised of cannabinoid receptors (type-1 and type-2), their endogenous ligands [referred to as endocannabinoids, of which anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are most studied] and proteins responsible for their metabolism, is involved in several physiological processes… 
Acupuncture- Mediated Activation of the Cholinergic Anti-Inflammatory Pathway- A Review of the Literature
TLDR
A neural pathway referred to as the “cholinergic anti-inflammatory pathway” plays a major role in suppressing inflammation.
Therapeutic implications of the endocannabinoid system in neurodegenerative diseases
TLDR
The purpose of this review is to present the available research and clinical data, up to date, regarding therapeutic perspectives of the endocannabinoid system in such neurodegenerative diseases.

References

SHOWING 1-10 OF 162 REFERENCES
The Endocannabinoid System: A Putative Role in Neurodegenerative Diseases
TLDR
The important role played by endocannabinoid system promises interesting developments, in particular to evaluate the effectiveness of new drugs in both psychiatry and neurology.
The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects
TLDR
The purpose of this review is to present the available in vivo and in vitro experimental data, up to date, regarding the endocannabinoid system and its role in neuroprotection, as well as its possible therapeutic perspectives.
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
TLDR
A comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy is provided.
Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.
TLDR
The role and therapeutic potential of ECS in neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease, multiple sclerosis, Huntington's Disease, Tourette's syndrome, brain ischemia and amyotrophic lateral sclerosis is discussed.
Acute neuronal injury, excitotoxicity, and the endocannabinoid system
TLDR
Several observations indicate that the role of the endocannabinoid system as a general endogenous protection system is questionable.
The role of endocannabinoids in pain modulation
TLDR
The purpose of this review is to present the available research and clinical data, up to date, regarding the ES and its role in pain modulation, as well as its possible therapeutic perspectives.
From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.
TLDR
In vivo studies using mice with experimental allergic encephalomyelitis suggest that the increase of the circulating levels of endocannabinoids might have a therapeutic effect, and that agonists of endOCannabinoids with low psychoactive effects could open new strategies for the treatment of multiple sclerosis.
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
TLDR
The study suggests that targeting the endocannabinoid system might be useful for the treatment of MS, and finds that anandamide (AEA), but not 2-arachidonoylglycerol (2-AG), was increased in the CSF of relapsing MS patients, and AEA concentrations were also higher in peripheral lymphocytes of these patients.
The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
TLDR
This review attempts to summarize recent advances in studies of CB2 activation in the setting of neuroinflammation, immunomodulation and HIV-1 infection.
...
1
2
3
4
5
...